Dasiglucagon Works for Kids; New Diabetes Dietary Guidelines; Post-COVID Thyroiditis

— News and commentary from the endocrinology world

MedpageToday
ENDOBREAK centered between 8 illustrated body organs.

Dasiglucagon reduced the need for IV glucose by 55% versus placebo in a pediatric population with congenital hyperinsulinism, according to a second phase III clinical trial by Zealand Pharma.

The American Diabetes Association praised Maryland Gov. Larry Hogan, Jr. (R), for signing into legislation a copay cap for insulin at $30 per monthly supply for those on state-regulated commercial health insurance plans.

Endorsed by the American Association of Clinical Endocrinology and co-sponsored by the Endocrine Society, the American College of Lifestyle Medicine released a new expert consensus statement on dietary interventions to treat type 2 diabetes, specifically for patients looking to put their diabetes in remission. (American Journal of Lifestyle Medicine)

New data found the Revita DMR procedure from Fractyl Health helped cut blood glucose, as well as improve long-term insulin resistance and pancreatic function. (Fierce Biotech)

Thyroiditis-areas at ultrasound scan are common in patients hospitalized for moderate-to-severe COVID-19 and may even continue to persist a year later, according to a study presented at the 2022 European Congress of Endocrinology. (Endocrine Abstracts)

A nurse at the University of Illinois Chicago School of Public Health penned an article arguing that the term "obesity" is racist, and instead suggested it be swapped out for terms like "people in larger bodies."

The FDA released new draft guidance for industry for the submission of premarket safety notification for new dietary ingredients and supplements.

According to a study presented at ACNAP-EuroHeartCare Congress 2022, eating low glycemic index foods -- such as fruits, vegetables, legumes, and whole grains -- will help people with coronary artery disease lose weight.

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.